These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8203867)

  • 1. Determination of pefloxacin concentration in mesenteric lymph nodes by high-performance chromatography.
    Munera MI; Cuesta F; Abadia A; Vasquez J; Restrepo M
    Antimicrob Agents Chemother; 1994 Mar; 38(3):632-4. PubMed ID: 8203867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular kinetics of pefloxacin after intramuscular administration in albino and pigmented rabbits.
    Cochereau-Massin I; Bauchet J; Faurisson F; Vallois JM; Lacombe P; Pocidalo JJ
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1112-5. PubMed ID: 1929251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report: pharmacokinetic and drug interaction studies of pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan.
    Gauhar S; Ali SA; Naqvi SB; Shoaib MH
    Pak J Pharm Sci; 2014 Mar; 27(2):389-95. PubMed ID: 24577931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal penetration of oral pefloxacin in humans.
    Oncel M; Peyman GA
    Int Ophthalmol; 1993 Aug; 17(4):217-22. PubMed ID: 8112969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics and tolerability of intravitreal pefloxacin in rabbits.
    Cochereau-Massin I; Marrakchi-Benjaafar S; Bauchet J; Vallois JM; Faurisson F; D'Hermies F; Pocidalo JJ
    J Antimicrob Chemother; 1994 Feb; 33(2):231-42. PubMed ID: 8182004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an antacid containing magnesium and aluminum on absorption, metabolism, and mechanism of renal elimination of pefloxacin in humans.
    Jaehde U; Sörgel F; Stephan U; Schunack W
    Antimicrob Agents Chemother; 1994 May; 38(5):1129-33. PubMed ID: 8067750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute epididymitis and antibiotherapy. Measurement of the epididymal diffusion of pefloxacin].
    Costa P; Galtier M; Laurelli JM; Nivard G; Louis JF; Favier M; Hansel S; Navratil H; Grasset D
    J Urol (Paris); 1989; 95(1):41-4. PubMed ID: 2732484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diffusion of pefloxacin in the aqueous humor and crystalline lens after repeated oral administration in man].
    Salvanet-Bouccara A; Montay G; Fisch A; Forestier F; Meziane D; Lafaix C; Prieur MB
    J Fr Ophtalmol; 1991; 14(4):260-4. PubMed ID: 1955654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of pefloxacin in plasma and tissue after administration as surgical prophylaxis.
    Jacoberger B; Ubeaud G; Freys G; Pottecher T; Jung L; Koffel JC
    Antimicrob Agents Chemother; 1998 Feb; 42(2):425-7. PubMed ID: 9527798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of pefloxacin and its desmethyl metabolite into the uroepithelium after a 800-mg single oral dose in human patients.
    Moreau JL; Royer-Morrot MJ; Lozniewski A; Trackoen G; Delavault P; Royer RJ
    Eur J Clin Pharmacol; 1996; 49(5):401-5. PubMed ID: 8866637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability, kinetics, and efficacy of subconjunctival pefloxacin in pigmented rabbits.
    Marrakchi-Benjaafar S; Cochereau I; D'Hermies F; Pocidalo JJ
    Antimicrob Agents Chemother; 1995 Apr; 39(4):834-8. PubMed ID: 7785980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of pefloxacin into bronchial secretions.
    Bonmarchand G; Grès JJ; Lerebours G; Massari P; Mayoux JJ; Montay A; Leroy J
    Antimicrob Agents Chemother; 1989 Mar; 33(3):391-3. PubMed ID: 2729932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of pefloxacin into gynaecological tissues.
    Bouvet O; Bressolle F; Courtieu C; Galtier M
    J Antimicrob Chemother; 1992 May; 29(5):579-87. PubMed ID: 1624396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of rifampin on the pharmacokinetics of pefloxacin.
    Humbert G; Brumpt I; Montay G; Le Liboux A; Frydman A; Borsa-Lebas F; Moore N
    Clin Pharmacol Ther; 1991 Dec; 50(6):682-7. PubMed ID: 1752112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pefloxacin pharmacokinetics and metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nikolaidis P; Walker SE; Dombros N; Tourkantonis A; Paton TW; Oreopoulos DG
    Perit Dial Int; 1991; 11(1):59-63. PubMed ID: 2049424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pefloxacin penetration into human necrotic pancreatic tissue.
    Bertazzoni Minelli E; Benini A; Muner A; Bassi C; Abbas H; Pederzoli P
    J Antimicrob Chemother; 1996 Aug; 38(2):237-43. PubMed ID: 8877537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of pefloxacin in goats after intravenous or oral administration.
    Malik JK; Rao GS; Ramesh S; Muruganandan S; Tripathi HC; Shukla DC
    Vet Res Commun; 2002 Feb; 26(2):141-9. PubMed ID: 11922483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration of pefloxacin in feces during infection prophylaxis in neutropenic patients.
    van de Leur JJ; Vollaard EJ; Janssen AJ; Dofferhoff AS
    Antimicrob Agents Chemother; 1995 May; 39(5):1182-4. PubMed ID: 7625811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of pefloxacin and its main active metabolite in human serum by high-performance liquid chromatography.
    Abanmi N; Zaghloul I; El Sayed N; Al-Khamis KI
    Ther Drug Monit; 1996 Apr; 18(2):158-63. PubMed ID: 8721279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of pefloxacin serum concentrations in intensive care unit patients: comparison of a new immunoassay with high-performance liquid chromatography.
    Lacarelle B; Le Guellec C; Morel A; Albanese J; Alazia M; Ballereau M; Llurens M; Bruno R; Francois G; Durand A
    Ther Drug Monit; 1994 Apr; 16(2):209-13. PubMed ID: 8009571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.